within Pharmacolibrary.Drugs.V_Various.V04C_OtherDiagnosticAgents.V04CE03_Methacetin13c;

model Methacetin13c
  extends Pharmacolibrary.Drugs.ATC.V.V04CE03;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>V04CE03</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Methacetin (13C) is a stable isotope-labeled derivative of methacetin used as a diagnostic agent for assessing liver function, particularly via the 13C-Methacetin Breath Test (MBT). It is not an approved therapeutic drug but is used in liver diagnostics to evaluate hepatic microsomal function and metabolic capacity.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters from healthy adult volunteers (mean age ~30-35 years) following intravenous administration reported in diagnostic liver function testing studies.</p><h4>References</h4><ol><li><p>Lock, JF, et al., &amp; Stockmann, M (2013). Predicting the prognosis in acute liver failure: results from a retrospective pilot study using the LiMAx test. <i>Annals of hepatology</i> 12(4) 556â€“562. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/23813133/\">https://pubmed.ncbi.nlm.nih.gov/23813133</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Methacetin13c;
